Publications by authors named "Matthias Noack-Rink"

Claim this Profile
C
Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
Simon Borghs, Laura Byram, Jane Chan, Peter Dedeken, John Logan, Matthias Noack-Rink

BMC Neurol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis.
Linda Kalilani, Xuezheng Sun, Barbara Pelgrims, Matthias Noack-Rink, Vicente Villanueva

Epilepsia· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
Simon Borghs, Solène Thieffry, Matthias Noack-Rink, Peter Dedeken, Lai San Hong

BMC Neurol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Bernd Pohlmann-Eden, Anthony G Marson, Matthias Noack-Rink, Francisco Ramirez, Azita Tofighy

BMC Neurol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
Uwe Runge, Stephan Arnold, Christian Brandt, Fritjof Reinhardt, Frank Kühn, Matthias Noack-Rink

Epilepsia· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis